E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 3/20/2024 in the Prospect News High Yield Daily.

New Issue: Medline sells $1 billion five-year secured notes at par to yield 6¼%

By Paul A. Harris

Portland, Ore., March 20 – Medline Industries, LP priced a $1 billion issue of Medline Borrower, LP five-year senior secured notes (B1/B+/BB-) at par to yield 6¼% on Wednesday, according to market sources.

The yield printed in the middle of yield talk in the 6¼% area. Initial guidance was in the mid-6% area.

Goldman Sachs & Co. LLC was the left bookrunner. Joint bookrunners were BofA Securities Inc., J.P. Morgan Securities LLC, Barclays, Morgan Stanley & Co. LLC, MUFG Securities Americas Inc., IMI Intesa Sanpaolo, Macquarie Capital (USA) Inc., Santander US Capital Markets LLC, BMO Capital Markets Corp., Citigroup Global Markets Inc., Deutsche Bank Securities Inc., HSBC Securities (USA) Inc., ING Financial Markets LLC, Jefferies LLC, UBS Securities LLC, U.S. Bancorp Investments Inc. and Wells Fargo Securities LLC.

The Northfield, Ill.-based health care company plans to use the proceeds to refinance a portion of its term loan.

Issuer:Medline Borrower, LP
Amount:$1 billion
Issue:Senior secured notes
Maturity:April 1, 2029
Left bookrunner:Goldman Sachs & Co. LLC
Joint bookrunners:BofA Securities Inc., J.P. Morgan Securities LLC, Barclays, Morgan Stanley & Co. LLC, MUFG Securities Americas Inc., IMI Intesa Sanpaolo, Macquarie Capital (USA) Inc., Santander US Capital Markets LLC, BMO Capital Markets Corp., Citigroup Global Markets Inc., Deutsche Bank Securities Inc., HSBC Securities (USA) Inc., ING Financial Markets LLC, Jefferies LLC, UBS Securities LLC, U.S. Bancorp Investments Inc. and Wells Fargo Securities LLC
Co-managers:Blackstone and TCG Capital Markets
Coupon:6¼%
Price:Par
Yield:6¼%
Spread:194 bps
First call:April 1, 2026 at 103.125
Special call:10% of notes annually at 103 during non-call period
Special call:All notes outstanding at par plus the full coupon with the proceeds of qualified IPO during first two years
Trade date:March 20
Settlement date:March 27
Ratings:Moody’s: B1
S&P: B+
Fitch: BB-
Distribution:Rule 144A and Regulation S for life
Price talk:6¼% area
Marketing:Roadshow
Cusip:58506DAA6, U8357DAA8

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.